We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current VAL market cap is 3.71M. The company's latest EPS is GBP -0.0154 and P/E is -1.82.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 0 | 0 | 0 | 0 | 9k |
| Operating Income | -2.98M | -1.64M | -1.67M | -2.6M | -2.3M |
| Net Income | -2.51M | -1.44M | -1.52M | -2.37M | -2.04M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 3.61M | 4.94M | 3.52M | 3.98M | 3.13M |
| Total Liabilities | 1.38M | 183k | 110k | 150k | 227k |
| Total Equity | 2.22M | 4.76M | 3.41M | 3.83M | 2.9M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | -1.34M | -1.91M | -1.26M | -1.71M | -1.77M |
| Investing | -250k | -91k | N/A | N/A | -306k |
| Financing | 1.21M | 3.85M | 7k | 2.26M | 1.12M |
| Market Cap | 3.71M |
| Price to Earnings Ratio | -1.82 |
| Price to Sales Ratio | 280 |
| Price to Cash Ratio | 21.54 |
| Price to Book Ratio | 1.28 |
| Dividend Yield | - |
| Shares Outstanding | 132.35M |
| Average Volume (1 week) | 841.83k |
| Average Volume (1 Month) | 684.4k |
| 52 Week Change | -59.71% |
| 52 Week High | 14.75 |
| 52 Week Low | 1.85 |
| Spread (Intraday) | 0.2 (6.9%) |
| Company Name | Valirx Plc |
| Address |
stonebridge house london CM22 7BD |
| Website | https://www.valirx.com |
| Industry | medical laboratories (8071) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
